Leukocytes apoptosis and adipocytokines in children with beta thalassemia major

Khalid I Elsayh1, Wafaa S Mohammed2, Asmaa M Zahran3

  • 1Pediatric Department, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt.

Insights

Beta-thalassemia major (BTM) patients in Egypt exhibit immune system abnormalities, including altered adipocytokine levels and increased T-lymphocyte apoptosis, contributing to infectious disease susceptibility.

Area of Science:

  • Immunology
  • Hematology
  • Public Health

Background:

  • Beta-thalassemia major (BTM) is a significant public health concern in Egypt.
  • Infectious complications are a leading cause of morbidity and mortality in BTM patients.
  • Immune system abnormalities, including inflammation and deficiency, increase susceptibility to infections.

Purpose of the Study:

  • To investigate immune system derangements in Egyptian children with BTM.
  • To compare serum levels of adipocytokines and inflammatory markers between BTM patients and healthy controls.
  • To assess apoptosis in lymphocytes and neutrophils in BTM patients.

Main Methods:

  • A case-control study involving 35 BTM patients and 30 healthy children.
  • Measurement of serum ferritin, high-sensitive C-reactive protein (hsCRP), leptin, and adiponectin.
  • Assessment of neutrophil and lymphocyte apoptosis using Annexin V-fluoroisothiocyanate binding assay.

Main Results:

  • BTM patients had significantly lower serum leptin, higher adiponectin, and higher hsCRP compared to controls.
  • Leptin levels negatively correlated with T-lymphocyte apoptosis.
  • BTM patients showed increased total leukocytes, neutrophils, lymphocytes, and significantly higher T-lymphocyte apoptosis.

Conclusions:

  • Disturbed adipocytokine profiles and elevated inflammatory markers are present in BTM patients.
  • Increased T-lymphocyte apoptosis may contribute to immune dysfunction in BTM.
  • These immunological disturbances could play a role in the increased infection risk in BTM.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
17.1K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.7K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.5K